ReviewEMBO reports2026
Polymerase face-off: emerging concepts in transcription-replication coordination.
Review in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Transcription-replication conflicts (TRCs) arise when DNA replication forks encounter actively transcribing RNA polymerases, creating a major threat to genome stability. These conflicts, which can occur in different orientations, disrupt replication fork progression, impair transcriptional fidelity and reshape the chromatin landscape. In this review, we discuss emerging conceptual insights into how cells coordinate replication and transcription in space and time to minimise such encounters, and we highlight the central role of RNA polymerase II dynamics in both preventing and resolving TRCs. We further describe how TRCs engage a broad network of genome maintenance pathways that regulate R-loops, stabilize stalled forks and maintain chromatin integrity. Importantly, elevated or mismanaged TRCs create vulnerabilities that many cancers exploit, positioning conflict-resolution mechanisms as attractive therapeutic targets. Finally, we examine current challenges in detecting and analysing these transient, dynamic events and underscore the need for improved imaging and sequencing technologies to study the genome's molecular "traffic jams". A deeper mechanistic understanding of TRCs will be crucial for harnessing them in precision oncology and clarifying their broader roles in genome regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.